North America Digital Therapeutics Market is segmented By Product Type (Software, Devices, Others), By Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others), By Sales Channel (Business-to-Business (B2B) (Employer, Healthcare Providers, Payers, Pharmaceutical Companies, Others), Business-to-Consumer (B2C) (Patient, Caregiver)), and By Country (U.S, Canada, Mexico) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Report Overview
The North America Digital Therapeutics Market is expected to grow at a CAGR of 20.6% over the forecast period 2024-2031.
The growing demand of the Digital Therapeutics market is supported by the following factors: Smartphones are being used as fitness and health monitoring tools, alongside their primary functions of communication and entertainment. Furthermore, the integration of big data in the healthcare sector is seeing notable expansion. The use of electronic health records and electronic medical record systems has seen an increase in popularity among individuals.
Additionally, the medical community has shown a positive reception towards telemedicine and telehealth services, which have gained recognition from both public and commercial institutions. Chronic diseases, including cancer, diabetes, cardiovascular disease, and Alzheimer's, are exhibiting an increasing incidence rate and need extended treatment and vigilant patient monitoring.
Report Scope
|
Metrics |
Details |
|
CAGR |
20.6% |
|
Size Available for Years |
2022-2031 |
|
Forecast Period |
2024-2031 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Product Type, Application, Sales Channel, and Country |
|
Countries Covered |
U.S., Canada, Mexico |
|
Largest Country |
U.S. |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics
Rising Prevalence of Chronic Diseases is driving the demand for digital therapeutics solutions
The rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases is driving the demand for digital therapeutics solutions. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for 6 in 10 deaths in the United States, and the healthcare costs associated with chronic diseases account for 90% of the country’s healthcare spending
The focus is on managing chronic diseases and ensuring data security and privacy.
The continued attention given to the management of chronic diseases such as diabetes, cardiovascular conditions, and obesity presents a continuous opportunity for digital therapeutics. These solutions can assist individuals in managing these conditions more effectively. With the rising adoption of digital health solutions, ensuring strong data security and privacy will become an important aspect of the market. Companies that offer secure solutions will find opportunities to cater to these needs.
Segmentation Analysis
The North America Digital Therapeutics Market is segmented into product type, application, sales channel and country
Geographical Shares
The North America Digital Therapeutics Market can be segmented into the U.S, Canada and Mexico.
The digital therapeutic (DTx) market is dominated by the North America region, which is expected to witness significant growth during the forecast period due to the rising number of diabetes cases. The United States(U.S), with the highest household spending in the world and favorable trade agreements with several countries, is the largest market for consumer products, including digital therapeutic (DTx) products.
North America Digital Therapeutics Key Players
Key players are Pear Therapeutics, Omada Health, Livongo (now part of Teladoc Health), Click Therapeutics, Akili Interactive Labs, Medtronic, WellDoc, BlueStar (by Welldoc).
